ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Development Of New Screening System For Antimetastasis Drugs Approved

June 25, 1982

In Brief: Senate Sets NCI rescission At $14 Million Baltimore Program Conversation To Cancer Center Will Be asked

May 15, 1981

In Brief: Henry Kaplan Dies Of Lung Cancer At 65; LED Development Of Hodgkin’s Disease Treatment

February 10, 1984

In Brief: Whittaker Corp, Trying To Hire NCI Director; Environmental Carcinogenesis On NCAB Agenda

February 13, 1976

ACS Modifies Pap Test Guidelines

November 27, 1987

Kington Named Acting NIH Director.

November 14, 2008